Funder
Fundação de Amparo à Pesquisa do Estado de São Paulo
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Otorhinolaryngology,Pathology and Forensic Medicine
Reference18 articles.
1. Balasubramaniam R, Sollecito TP, Stoopler ET. Oral health considerations in muscular dystrophies. Spec Care Dentist. 2008;28(6):243–53.
2. Palomo Atance E, Ballester Herrera MJ, Márquez de La Plata MA, Medina Cano E, Carmona Vilchez RM. Alendronate treatment of osteoporosis secondary to Duchenne muscular dystrophy. An Pediatr Barc. 2011; 74(2): 122–125.
3. Bushby K, Finkel R, Birnkrant DJ, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2010;9(1):77–93.
4. Bell JM, Shields MD, Watters J, et al. Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy. Cochrane Database Syst Rev. 2017;1:CD010899.
5. Chiodini I, Catalano A, Gennari L, Gaudio A. Osteoporosis and fragility fractures in type 2 diabetes. J Diabetes Res. 2020;2020:9342696.